Sequencing Reagents Market Size
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 7.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Sequencing Reagents Market Analysis
The Sequencing Reagents Market is expected to register a CAGR of 7.5% during the forecast period. This is attributing to increasing demand for third-generation sequencing, decreasing costs for genetic sequencing, and increasing R&D expenditure on genomic research. In addition, developments in sequencing technologies to provide high yield data for large scale genomic research and availability of new commercial reagents kits for specific sequencing technologies will also promote the growth of the sequencing reagents market. Nanopore and single-molecule real-time sequencing are some of the novel technologies, with its cost-effective and efficient preparation of sequencing the DNA results in adoption by researchers to sequence the genome in a short time and less cost. Moreover, the cost of genetic sequencing has been falling from USD 10-15 million per genome in 2001 to USD 1,200 per genome in 2017. Thus, the declining cost of genetic sequencing will boost the growth sequencing technologies, and which further drive the use of sequencing reagents. Furthermore, favorable government initiatives and increasing funding of private and public entities will also trigger the growth of sequencing technologies and propel the demand for sequencing reagents in the forecasted period.
Sequencing Reagents Market Trends
This section covers the major market trends shaping the Sequencing Reagents Market according to our research experts:
Next Generation Sequencing (NGS) is Estimated to Witness a Healthy Growth in Future.
Next-generation sequencing (NGS) is estimated to witness a healthy growth in the future attributed to increasing adoption of several applications such as molecular pathology, molecular diagnostics, and other clinical research applications. The all in one and deep sequencing approach offered by NGS will minimize the time required to identify the root of the condition and helps in determining novel or rare variants. Moreover, the use of next-generation sequencing technologies in personalized medicines, companion diagnostic and in-vitro diagnostics led to high adoption compared to others and promotes the segment growth.
In Addition, As per Pharmaceutical Research & Manufacturer of America, biopharmaceutical research & development expenditure has been rising up from past years leading to drive the sequencing reagents market in the forecasted period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Sequencing Reagents Market due to the rising prevalence of chronic diseases, the presence of a large number of pharmaceutical companies, growing research and development expenditure, rising awareness, product launches, and technological advancements. The United States owns the largest share of Sequencing Reagents Market in the North America region Furthermore, increasing adoption of novel sequencing technologies, well-established infrastructure, and increasing healthcare expenditure are also expected to fuel the Sequencing Reagents Market in this region.
Sequencing Reagents Industry Overview
The Sequencing Reagents Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are F. Hoffmann-La Roche AG, Illumina, Inc, Thermo Fisher Scientific, Oxford Nanopore Technologies, Agilent Technologies, Inc., BGI, Bioline, Qiagen, Takara Bio Inc., and Fluidigm Corporation.
Sequencing Reagents Market Leaders
-
F. Hoffmann-La Roche AG
-
Illumina, Inc
-
Thermo Fisher Scientific
-
Oxford Nanopore Technologies
-
Agilent Technologies, Inc.
*Disclaimer: Major Players sorted in no particular order
Sequencing Reagents Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Demand for Third Generation Sequencing
-
4.2.2 Decreasing Costs for Genetic Sequencing
-
4.2.3 Increasing R&D Expenditure
-
-
4.3 Market Restraints
-
4.3.1 Limited Reimbursement Policy and Regulation for NGS
-
4.3.2 Ethical and Social Issues Associated with Sequencing
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Template Kits
-
5.1.2 Library Kits
-
5.1.3 Control Kits
-
5.1.4 Sequencing Kits
-
5.1.5 Others
-
-
5.2 By Technology
-
5.2.1 Next Generation Sequencing
-
5.2.2 Sanger Sequencing
-
5.2.3 Third Generation Sequencing
-
-
5.3 By Application
-
5.3.1 Clinical Investigation
-
5.3.2 Oncology
-
5.3.3 Forensics & Agrigenomics
-
5.3.4 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 F. Hoffmann-La Roche AG
-
6.1.2 Illumina, Inc
-
6.1.3 Thermo Fisher Scientific
-
6.1.4 Oxford Nanopore Technologies
-
6.1.5 Agilent Technologies, Inc.
-
6.1.6 BGI
-
6.1.7 Bioline
-
6.1.8 Qiagen
-
6.1.9 Takara Bio Inc.
-
6.1.10 Fluidigm Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Sequencing Reagents Industry Segmentation
As per the scope, sequencing reagents are used in the process of DNA sequencing, an important tool to determine the order of nucleotides. DNA sequencing has several types of research, the diagnostic and therapeutic application includes drug discovery, forensics, genomics, cancers, infectious disease, and many more.
By Type | |
Template Kits | |
Library Kits | |
Control Kits | |
Sequencing Kits | |
Others |
By Technology | |
Next Generation Sequencing | |
Sanger Sequencing | |
Third Generation Sequencing |
By Application | |
Clinical Investigation | |
Oncology | |
Forensics & Agrigenomics | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Sequencing Reagents Market Research FAQs
What is the current Sequencing Reagents Market size?
The Sequencing Reagents Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Sequencing Reagents Market?
F. Hoffmann-La Roche AG, Illumina, Inc, Thermo Fisher Scientific, Oxford Nanopore Technologies and Agilent Technologies, Inc. are the major companies operating in the Sequencing Reagents Market.
Which is the fastest growing region in Sequencing Reagents Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Sequencing Reagents Market?
In 2024, the North America accounts for the largest market share in Sequencing Reagents Market.
What years does this Sequencing Reagents Market cover?
The report covers the Sequencing Reagents Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sequencing Reagents Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Sequencing Reagents Industry Report
Statistics for the 2024 Sequencing Reagents market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sequencing Reagents analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.